Wei Guo Su
Chief Executive Officer at HUTCHMED (CHINA) LIMITED
Net worth: 18 M $ as of 30/04/2024
Wei Guo Su active positions
| Companies | Position | Start | End |
|---|---|---|---|
| HUTCHMED (CHINA) LIMITED | Director/Board Member | 27/03/2017 | - |
| Chief Executive Officer | 04/03/2022 | - | |
| Chief Tech/Sci/R&D Officer | 01/01/2012 | - | |
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Chief Tech/Sci/R&D Officer | 24/03/2010 | - |
Career history of Wei Guo Su
Former positions of Wei Guo Su
| Companies | Position | Start | End |
|---|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - | - |
Training of Wei Guo Su
| Harvard University | Doctorate Degree |
| Fudan University | Undergraduate Degree |
Statistics
International
| United States | 3 |
| China | 3 |
| Hong Kong | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| HUTCHMED (CHINA) LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
- Stock Market
- Insiders
- Wei Guo Su
- Experience
